Volver a Agenda
Panel Discussion (Session 2 & 3)
Session Chair(s)
Koichi Miyazaki, PhD
Senior Director, Group IV, Oncology Clinical Development Department, Daiichi Sankyo Co., Ltd., Japan
Yoshiaki Uyama, PhD, MS, RPh
Associate Executive Director, Regulatory Science Center, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gau Churn-Shiouh, DRSc
Office Director, Project Office of Sustainable Platform For Big Data In Health by MOHW, Ching-Kan, Taiwan
Sun-young Kim, MS
Assistant Director, Clinical Trials Management Div, Pharmaceutical Safety Bureau, Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Akihiro Ishiguro, PhD
Head, PMDA Washington D.C. Office, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Tetsuomi Takano, RPh
Editor-in-Chief, Drug R&D Expert, Japan
Yamin Wang, PhD
Vice President & Head of Regulatory Affairs, Therapeutic Area General Medicine, Bayer (South East Asia) Pte Ltd., Germany
Minsoo Park
, KCGI, Korea, Republic of
¿Tiene una cuenta?